VISN 15 A1C cprr testing BPA to fund the 4-month extension.
Ended Awarded Last action
- Contract number
- 36C25525N0297
- Awardee
-
Tosoh Bioscience, Inc. UEI Q9YNUD9SW2J8
- Awarding agency
-
Veterans Integrated Service Network 15
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $85,476
Award facts
- Opportunity
-
- 36C25525AP0593 Solicitation number
- Contract value 100% obligated
- $85,476.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6630 Chemical Analysis Instruments
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- South San Francisco, CA 94080, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$2,759 | |
| Supplemental Agreement for work within scope | -$13,255 | |
| Supplemental Agreement for work within scope | $1,490 | |
| Original award | $100,000 |
About this award
Tosoh Bioscience, Inc. (doing business as Tosoh USA) received a $85,476.39 firm fixed-price Blanket Purchase Agreement (BPA) call from Veterans Integrated Service Network 15 (VISN 15) to fund a four-month extension of hemoglobin A1C (HbA1c) cost-per-reportable-result (CPRR) testing services through September 30, 2025. This BPA call, awarded June 1, 2025, is issued under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule and carries no small business set-aside designation. The work is being performed in South San Francisco, California, where Tosoh Bioscience maintains its headquarters as a foreign-owned, for-profit manufacturer specializing in high-performance liquid chromatography (HPLC) testing instrumentation and related clinical diagnostic supplies essential for diabetes diagnosis and management across VA healthcare networks.
This award supports VISN 15's de-obligation and continuation of A1C testing capabilities at Kansas City VA Medical Center (KC VAMC) and represents one of numerous contract vehicles Tosoh Bioscience maintains across the Department of Veterans Affairs. The company holds an extensive portfolio of approximately $10.6 million in federal IDVs across multiple VA networks, enabling the provision of hemoglobin analyzers (including the Tosoh G8 analyzer), reagents, consumables, and CPRR testing services to support clinical laboratory operations and veteran healthcare delivery. As a prime contractor with no identified subcontractors on this award, Tosoh Bioscience continues to serve as a critical supplier of advanced diagnostic laboratory capabilities to the VA's diabetes management and clinical testing infrastructure.
Quick answers
Who was awarded contract 36C25525N0297?
36C25525N0297 was awarded to Tosoh Bioscience, Inc. by Veterans Integrated Service Network 15 (Veterans Health Administration) on June 1, 2025.
How much is contract 36C25525N0297 worth?
The government has obligated $85,476 on 36C25525N0297.
Is contract 36C25525N0297 an order under another contract?
Yes. 36C25525N0297 is a BPA call under V797D40130-36C25520A0026, a blanket purchase agreement, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract 36C25525N0297 competed?
The extent of competition for 36C25525N0297 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award